WSI Co Ltd
KOSDAQ:299170
Intrinsic Value
WSI Co., Ltd. manufactures medical devices and pharmaceutical products. [ Read More ]
The intrinsic value of one WSI Co Ltd stock under the Base Case scenario is 2 508.11 KRW. Compared to the current market price of 3 210 KRW, WSI Co Ltd is Overvalued by 22%.
Valuation Backtest
WSI Co Ltd
Run backtest to discover the historical profit from buying and selling WSI Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
WSI Co Ltd
Current Assets | 23.3B |
Cash & Short-Term Investments | 9.4B |
Receivables | 9.8B |
Other Current Assets | 4.1B |
Non-Current Assets | 37.6B |
Long-Term Investments | 14B |
PP&E | 22.4B |
Intangibles | 799.2m |
Other Non-Current Assets | 437.6m |
Current Liabilities | 18.5B |
Accounts Payable | 1.2B |
Accrued Liabilities | 542.7m |
Other Current Liabilities | 16.8B |
Non-Current Liabilities | 2.7B |
Long-Term Debt | 469.1m |
Other Non-Current Liabilities | 2.2B |
Earnings Waterfall
WSI Co Ltd
Revenue
|
30.2B
KRW
|
Cost of Revenue
|
-19.6B
KRW
|
Gross Profit
|
10.6B
KRW
|
Operating Expenses
|
-6.6B
KRW
|
Operating Income
|
4B
KRW
|
Other Expenses
|
-1.3B
KRW
|
Net Income
|
2.7B
KRW
|
Free Cash Flow Analysis
WSI Co Ltd
Profitability Score
Profitability Due Diligence
WSI Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
WSI Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
WSI Co Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Score
WSI Co Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
WSI Co Ltd
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
WSI Co., Ltd. manufactures medical devices and pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-09-21. The firm mainly distributes the topical hemostatic agent Flosils. In addition, the Company supplies endoscopes related to spinal surgery, anti-adhesion agents, and bone hemostatic agents.
Contact
IPO
Employees
Officers
The intrinsic value of one WSI Co Ltd stock under the Base Case scenario is 2 508.11 KRW.
Compared to the current market price of 3 210 KRW, WSI Co Ltd is Overvalued by 22%.